Table 4.
Measure | Treatment | N | F (df) for ANOVA; Chi square (df) for Kruskal-Wallis | p-Value | Effect sizes: partial-eta-square (ANOVA); Episilon-square (Kruskal-Wallis) | Post hocs | Outliers (n, if any) | ||
---|---|---|---|---|---|---|---|---|---|
Vaginal opening (days of age) | |||||||||
Maternal females | VEH | 13 | 0.46 | 0.04 | 2 | ||||
A1221 | 12 | ||||||||
VIN | 17 | ||||||||
Paternal females | VEH | 17 | 0.001 | 0.27 |
|
2 | |||
A1221 | 16 | ||||||||
VIN | 15 | ||||||||
Preputial separation (days of age) | |||||||||
Maternal males | VEH | 13 | 0.36 | 0.05 | 2 | ||||
A1221 | 13 | ||||||||
VIN | 16 | 2 | |||||||
Paternal males | VEH | 19 | 0.60 | 0.02 | |||||
A1221 | 16 | 2 | |||||||
VIN | 22 | ||||||||
Adrenosomatic index | |||||||||
Maternal females | VEH | 11 | 0.09 | 0.13 | No post hoc differences | 2 | |||
A1221 | 10 | ||||||||
VIN | 18 | ||||||||
Paternal females | VEH | 11 | 0.46 | 0.06 | |||||
A1221 | 10 | ||||||||
VIN | 9 | ||||||||
Maternal males | VEH | 10 | 0.02 | 0.23 |
|
1 | |||
A1221 | 9 | ||||||||
VIN | 13 | 1 | |||||||
Paternal males | VEH | 13 | 0.001 | 0.32 |
|
||||
A1221 | 12 | ||||||||
VIN | 15 | ||||||||
Gonadosomatic index | |||||||||
Maternal females | VEH | 10 | 0.89 | 0.01 | |||||
A1221 | 12 | ||||||||
VIN | 18 | ||||||||
Paternal females | VEH | 10 | 0.92 | 0.01 | |||||
A1221 | 10 | ||||||||
VIN | 9 | ||||||||
Maternal males | VEH | 11 | 0.20 | 0.10 | 1 | ||||
A1221 | 9 | ||||||||
VIN | 14 | ||||||||
Paternal males | VEH | 13 | 0.03 | 0.18 | , | 2 | |||
A1221 | 11 | 1 | |||||||
VIN | 15 | ||||||||
Corticosterone () | |||||||||
Maternal females | VEH | 10 | 0.31 | 0.08 | |||||
A1221 | 9 | ||||||||
VIN | 11 | ||||||||
Paternal females | VEH | 11 | 0.81 | 0.02 | |||||
A1221 | 9 | ||||||||
VIN | 9 | 1 | |||||||
Maternal males | VEH | 10 | 0.41 | 0.07 | |||||
A1221 | 9 | ||||||||
VIN | 10 | ||||||||
Paternal males | VEH | 10 | 0.46 | 0.06 | |||||
A1221 | 10 | ||||||||
VIN | 8 | 2 | |||||||
Estradiol () | |||||||||
Maternal females | VEH | 10 | 0.94 | 0.00 | |||||
A1221 | 8 | 1 | |||||||
VIN | 10 | 1 | |||||||
Paternal females | VEH | 11 | 0.59 | 0.04 | |||||
A1221 | 10 | ||||||||
VIN | 10 | ||||||||
Maternal males | VEH | 10 | 0.37 | 0.08 | |||||
A1221 | 8 | 1 | |||||||
VIN | 10 | ||||||||
Paternal males | VEH | 10 | 0.04 | 0.22 | , | ||||
A1221 | 10 | ||||||||
VIN | 9 | 1 | |||||||
Testosterone () | |||||||||
Maternal males | VEH | 8 | 0.60 | 0.04 | 2 | ||||
A1221 | 9 | ||||||||
VIN | 10 | ||||||||
Paternal males | VEH | 10 | 0.01 | 0.28 |
|
||||
A1221 | 9 | 1 | |||||||
VIN | 10 |
Note: Data are shown as . Statistics are presented with F-(ANOVA) or Chi-square values (Kruskal-Wallis). Degrees of freedom (df) are shown parenthetically. An effect size of 0.14 is large, and between 0.06 and 0.13 is medium. Numbers of outliers in a group (up to 2 calculated by the Grubb’s test) are indicated. Adrenosomatic index was calculated as: ; gonadosomatic index was calculated as: . A1221, Aroclor 1221; VEH, vehicle; VIN, vinclozolin.